SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing intense selling pressure following a disappointing quarterly forecast, with investors openly questioning the company's long-term growth trajectory and leadership. The community is deeply divided between those calling for a structural 'value trap' exit and others aggressively buying the dip, citing its iconic global brand status as a potential catalyst for a future turnaround.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is currently trading in the spotlight as investors brace for the upcoming March delivery report and first-quarter figures, with the community closely tracking whether recent sales momentum and new model launches can drive a break above key resistance levels. Discussions remain polarized, pitting bulls who anticipate a strong growth trajectory and potential short squeeze against bears who express continued skepticism regarding long-term profitability and historical price performance.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as investors weigh mixed sentiment regarding global expansion and beverage partnerships against ongoing concerns about financial performance and potential share dilution. The community remains deeply divided, with some betting on a short squeeze or a potential rebound linked to cannabis rescheduling, while others remain skeptical due to the stock's long-term downward trend.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors aggressively debate the company's aggressive Bitcoin acquisition strategy and the impact of recent dilution on shareholder value. Community sentiment is deeply polarized, with bulls viewing the stock as a prime leverage play on Bitcoin's long-term potential, while critics raise concerns over debt levels, the viability of its financing model, and the sustainability of its institutional treasury approach.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched NASA ETF is generating significant buzz as traders compare its exposure to space-sector heavyweights like SpaceX against other established funds. While many in the community are debating the fund's low initial assets under management and the validity of its holdings, momentum traders are actively discussing its potential for volatility and speculative growth.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently experiencing significant downward pressure as investors weigh cooling growth prospects against mounting legal risks stemming from recent court rulings on addictive product design. While some in the community are treating the rapid price pullback as a buying opportunity for long-term AI-driven upside, others are bracing for further volatility due to broader geopolitical tensions and institutional concerns about the company's liability outlook.

Ganymede

Ganymede is gaining attention as traders highlight its clean price structure and steady accumulation patterns. The community is actively discussing the potential for a breakout, viewing the current consolidation as a sign of underlying strength and controlled momentum.

Maul Coin

Maul Coin is generating buzz among retail traders who are actively rallying to drive organic growth and push the project toward higher market cap milestones. The community is focused on transparent leadership, coin burns, and social momentum to distinguish the token from typical memecoin hype cycles.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy Co. is experiencing intense volatility and trading volume as investors speculate on potential oil exploration success in the Jameson Land Basin following a strategic drilling agreement. The community is actively debating the company's valuation and long-term viability, with many retail traders highlighting the stock's potential for a significant short squeeze amidst ongoing geopolitical energy concerns.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is in the spotlight as investors track its ongoing role in high-stakes aerospace projects like the Artemis II launch and critical missile defense system upgrades. The community is actively discussing the stock's stability within the defense sector, balancing the long-term tailwinds of government spending against concerns over contract execution and market reactions to geopolitical headlines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Connect Biopharma (NASDAQ:CNTB) Receives "Buy" Rating from BTIG Research

BTIG Research restated a "buy" rating and issued a $10.00 price target on shares of Connect Biopharma in a research report on Tuesday...

Connect Biopharma touts rapid IV rademikibart FEV1 gains; Phase 3 atopic dermatitis data impresses

Connect Biopharma (NASDAQ:CNTB) shared new clinical and preclinical updates on rademikibart, its IL-4 receptor alpha monoclonal antibody, highlighting preliminary top-line results from an intravenous...

Connect Biopharma (CNTB) Expected to Announce Earnings on Monday

Connect Biopharma (NASDAQ:CNTB) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-connect-biopharma-holdings-limited-american-depositary-shares-stock...

Connect Biopharma Touts Next-Gen Dupixent Rademikibart, Near-Term Asthma/COPD Readouts

Connect Biopharma (NASDAQ:CNTB) CEO Barry Quart outlined the company's focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a next-generation DUPIXENT, during a...

Connect Biopharma Touts Rademikibart as Fast-Acting Option for Acute Asthma, COPD Flare-Ups at Conference

Connect Biopharma (NASDAQ:CNTB) CEO Barry Quart told investors at Oppenheimer's 36th Annual Healthcare Life Science Conference that the company is advancing its lead asset, rademikibart, into what it...

BML Capital Management LLC Sells 554,058 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB

BML Capital Management LLC cut its stake in Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) by 30.4% during the third quarter, according to its most recent 13F filing...

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors  DelveInsight

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the five ratings firms that are...

Equities Analysts Offer Predictions for CNTB FY2030 Earnings

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Equities research analysts at HC Wainwright issued their FY2030 earnings estimates for Connect Biopharma in a report...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives Average Rating of "Moderate Buy" from Brokerages

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five brokerages that are currently covering the...

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.

Connect Biopharma Holdings Ltd

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

CNTB
Connect Biopharma Holdings Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest CNTB News

CNTBConnect Biopharma Holdings Ltd - ADR